{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:28:00Z","timestamp":1767374880449,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bbr.2019.03.035","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T12:40:30Z","timestamp":1553776830000},"page":"166-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Repeated treatments with the D1 dopamine receptor agonist SKF-38393 modulate cell viability via sustained ERK\u2013Bad\u2013Bax activation in dopaminergic neuronal cells"],"prefix":"10.1016","volume":"367","author":[{"given":"Hyun Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun Hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3327-3481","authenticated-orcid":false,"given":"Myung Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.03.035_bib0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0969-8051(98)00054-7","article-title":"Modeling dopamine system dysfunction in experimental animals","volume":"25","author":"Hantraye","year":"1998","journal-title":"Nuclear Med. Biol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0010","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/466S6a","article-title":"Levodopa: the story so far","volume":"466","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2019.03.035_bib0015","first-page":"S167","article-title":"Dopamine agonists and neuroprotection in Parkinson\u2019s disease","volume":"44","author":"Olanow","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jnnp.68.6.685","article-title":"Dopamine agonists: their role in the treatment of Parkinson\u2019s disease","volume":"68","author":"Brooks","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2019.03.035_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.09.013","article-title":"Priming for L-DOPA-induced dyskinesia in Parkinson\u2019s disease: a feature inherent to the treatment of the disease?","volume":"87","author":"Nadjar","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuint.2005.09.007","article-title":"Dopamine D1 receptor-mediated toxicity in human SK-N-MC neuroblastoma cells","volume":"48","author":"Moussa","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2019.03.035_bib0035","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1091\/mbc.e05-05-0432","article-title":"Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells","volume":"16","author":"Kiermayer","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbr.2019.03.035_bib0040","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/jnr.23450","volume":"92","author":"Park","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2019.03.035_bib0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(00)01690-6","article-title":"The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor","volume":"297","author":"Lambeng","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.03.035_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfs139","article-title":"Modulation of PC12 cell viability by forskolin\u2013induced cyclic AMP levels through ERK and JNK pathways: an implication for L-DOPA-induced cytotoxicity in nigrostriatal dopamine neurons","volume":"128","author":"Park","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2015.09.006","article-title":"L-DOPA modulates cell viability through the ERK-c-Jun system in PC12 and dopaminergic neuronal cells","volume":"101","author":"Park","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.03.035_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02355-6","article-title":"Cocaine inhibits NGF-induced PC12 cells differentiation through D1-type dopamine receptors","volume":"869","author":"Zachor","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.03.035_bib0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0197-0186(03)00150-5","article-title":"cAMP-activated pathway, including PKA and PI3K, regulated neuronal differentiation","volume":"44","author":"Sanchez","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2019.03.035_bib0070","doi-asserted-by":"crossref","first-page":"39317","DOI":"10.1074\/jbc.M403891200","article-title":"Dopamine D1 receptor mediates dopamine\u2013induced cytotoxicity via the ERK signal cascade","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1460-9568.2008.06590.x","article-title":"Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades","volume":"29","author":"Chen","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0080","doi-asserted-by":"crossref","first-page":"16436","DOI":"10.1074\/jbc.M512430200","article-title":"Opposing roles for ERK1\/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1\/2 action at early versus late phases of oxidative stress","volume":"281","author":"Luo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0085","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1471-4159.1995.64020825.x","article-title":"L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation","volume":"64","author":"Basma","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0090","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1172\/JCI117946","article-title":"Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson\u2019s disease","volume":"95","author":"Walkinshaw","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2019.03.035_bib0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0006-8993(96)01056-6","article-title":"Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons","volume":"743","author":"Cheng","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.03.035_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2008.06.052","article-title":"Induction of dopamine biosynthesis by L-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP","volume":"591","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0105","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.tiv.2013.09.014","article-title":"The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells","volume":"27","author":"Park","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bbr.2019.03.035_bib0110","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbr.2019.03.035_bib0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1471-4159.2007.04601.x","article-title":"Contrasting roles of neuronal Msk1 and Rsk2 in Bad phosphorylation and feedback regulation of Erk signaling","volume":"102","author":"Clark","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0120","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1074\/jbc.271.13.7440","article-title":"Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2","volume":"271","author":"Zha","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0125","doi-asserted-by":"crossref","first-page":"25865","DOI":"10.1074\/jbc.M004199200","article-title":"BAD Ser-155 phosphorylation regulates BAD\/Bcl-XL interaction and cell survival","volume":"275","author":"Tan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0130","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1074\/jbc.M209941200","article-title":"Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria","volume":"278","author":"Affaitati","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0135","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1523\/JNEUROSCI.0528-04.2004","article-title":"Sustained extracellular signal-regulated kinase 1\/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement","volume":"24","author":"Papadeas","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/jbbs.2012.21001","article-title":"The time course of D1 agonist induced striatonigral ERK1\/2 signaling in a rat model of Parkinson\u2019s disease","volume":"2","author":"Moreno","year":"2012","journal-title":"J. Behav. Brain Sci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0145","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1523\/JNEUROSCI.2702-13.2014","article-title":"Mechanisms of dopamine D1 receptor-mediated ERK1\/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5","volume":"34","author":"Fieblinger","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02246952","article-title":"Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice","volume":"110","author":"Tirelli","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2019.03.035_bib0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2012.02.041","article-title":"SKF 38393 reverses cocaine-conditioned place preference in mice","volume":"513","author":"Sabioni","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.03.035_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(82)90003-8","article-title":"Neostriatal encephalin immunoreactive neurons project to the globus pallidus","volume":"231","author":"Del Fiacco","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.03.035_bib0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neurosci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2014.04.015","article-title":"Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson\u2019s disease","volume":"1567","author":"Shin","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.03.035_bib0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1471-4159.1983.tb11291.x","article-title":"Glucocorticoids increase catecholamine synthesis and storage in PC12 cells pheochromocytoma cell culture","volume":"40","author":"Tischler","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2015.01.003","article-title":"Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson\u2019s disease rat models","volume":"83\u201384","author":"Park","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2019.03.035_bib0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1083\/jcb.89.2.240","article-title":"Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells","volume":"89","author":"Gunning","year":"1981","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028946","article-title":"Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways","volume":"6","author":"Beauvais","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.03.035_bib0195","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/152308603770310257","article-title":"Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis","volume":"5","author":"Kirkland","year":"2003","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbr.2019.03.035_bib0200","first-page":"508","article-title":"Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain, Naunyn-Schmiedeberg\u2019s","volume":"335","author":"Kelly","year":"1987","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0205","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/33293","article-title":"Signal transduction: taking the Rap","volume":"392","author":"Marshall","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2019.03.035_bib0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/jnr.21478","article-title":"Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells","volume":"86","author":"Lin","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2019.03.035_bib0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10495-006-0524-8","article-title":"Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress","volume":"12","author":"Chan","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbr.2019.03.035_bib0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02970136","article-title":"Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity","volume":"28","author":"Kulich","year":"2003","journal-title":"J. Biosci."},{"key":"10.1016\/j.bbr.2019.03.035_bib0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1097-2765(05)00012-2","article-title":"14\u20133\u20133 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation","volume":"6","author":"Datta","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbr.2019.03.035_bib0230","doi-asserted-by":"crossref","first-page":"22357","DOI":"10.1074\/jbc.M300742200","article-title":"JNK-independent activation of c-Jun during neuronal apoptosis induced by multiple DNA-damaging agents","volume":"278","author":"Besirli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.03.035_bib0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbr.2019.03.035_bib0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2019.03.035_bib0245","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbr.2019.03.035_bib0250","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/npp.2009.74","article-title":"Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson\u2019s disease","volume":"34","author":"Lindgren","year":"2009","journal-title":"Neuropsychopharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818317637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818317637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:12:34Z","timestamp":1759065154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818317637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":50,"alternative-id":["S0166432818317637"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.03.035","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated treatments with the D1 dopamine receptor agonist SKF-38393 modulate cell viability via sustained ERK\u2013Bad\u2013Bax activation in dopaminergic neuronal cells","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}